e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Management of sarcoidosis and lung manifestations of systemic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The association between Takotsubo cardiomyopathy and lung diseases
M. G. Lee, C. Y. Lee, G. W. Kim (Chuncheon, Republic Of Korea)
Source:
Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Session:
Management of sarcoidosis and lung manifestations of systemic diseases
Session type:
Thematic Poster Session
Number:
605
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. G. Lee, C. Y. Lee, G. W. Kim (Chuncheon, Republic Of Korea). The association between Takotsubo cardiomyopathy and lung diseases. Eur Respir J 2010; 36: Suppl. 54, 605
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Four cases of clinical analysis with Takotsubo cardiomyopathy associated with bronchoscopy
Source: International Congress 2017 – Bronchoscopy: from stents to practical tips and tricks
Year: 2017
Acute cardiomyopathy in rheumatoid associated lung disease
Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases
Year: 2011
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018
Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?
Source: Eur Respir J 2013; 41: 243-245
Year: 2013
Genetics of fibrosing lung diseases
Source: Eur Respir J 2005; 25: 915-927
Year: 2005
Relationship between exercise tolerance and spirometric data in a group of patients affected by idiopathic dilated cardiomyopathy
Source: Eur Respir J 2001; 18: Suppl. 33, 84s
Year: 2001
Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019
Year: 2020
Williams-Campbell syndrome (W-C s) in the patient with noncompaction cardiomyopathy (NCCM)- coexistance of rare congenital disorders
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010
Noninvasive ventilation (NIV) in acute decompensated heart failure (ADHF) in patients with ischemic and idiopathic dilated cardiomyopathy
Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation
Year: 2007
Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019
Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Prevalence of lung function abnormalities in smokers with ischemic heart disease
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
Source: Eur Respir J 2012; 40: 377-385
Year: 2012
Echocardiographic indices of right ventricular sizes and function in patients with moderate and severe chronic obstructive pulmonary disease, with the past history of myocardial infarction
Source: Eur Respir J 2007; 30: Suppl. 51, 127s
Year: 2007
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012
Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
Source: Eur Respir Rev, 27 (150) 180110; 10.1183/16000617.0110-2018
Year: 2018
Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Heart arrhythmias in patients with chronic obstructive bronchitis and ischemic heart disease
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
Left ventricular dysfunction in patients with interstitial lung diseases
Source: Eur Respir J 2009; 33: 702-703
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept